Skip to content
healthcare.dev

LACOSAMIDE

NDC 31722-203, LACOSAMIDE, injection, from Camber Pharmaceuticals, Inc..

Product NDC
31722-203
Status
Listed
Labeler
Camber Pharmaceuticals, Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216335
DEA schedule
CV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/31722-203 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LACOSAMIDE10 mg/mL

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
31722-203-313172202033110 VIAL, GLASS in 1 CARTON (31722-203-31) / 20 mL in 1 VIAL, GLASS (31722-203-20)
31722-203-333172202033310 VIAL, GLASS in 1 CARTON (31722-203-33) / 20 mL in 1 VIAL, GLASS (31722-203-32)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e24d3c45-a559-4fca-a7be-74ce37a7066e

Use it

Look up 31722-203 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/31722-203 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 31722-203. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.